Latest News
|
19 June 2013
0 Likes
When US legislators and President Barack Obama signed the Food and Drug Administration Safety and Innovation Act (FDASIA) into law in July 2012, they did so – among other reasons – in the hope that
Read More...
Latest News
|
17 June 2013
0 Likes
For years, regulators around the globe have been touting the challenges and benefits of globalization, explaining that a globally diverse product supply chain means needing to rely on regulatory
Read More...
Latest News
|
14 May 2013
0 Likes
The Pharmaceutical Inspection Convention and Cooperation Scheme (PIC/S), an international forum for the exchange of regulatory information about pharmaceutical products, may soon see itself with two
Read More...
Latest News
|
13 May 2013
1 Likes
The US Food and Drug Administration (FDA) may still be in the midst of figuring out how to overhaul its medical device compliance approach in regards to quality, but a new report out from device
Read More...
Latest News
|
25 February 2013
0 Likes
In a wide-ranging speech before the Generic Pharmaceutical Association's annual meeting in Florida, US Food and Drug Administration (FDA) Commissioner Margaret Hamburg said her regulatory agency will
Read More...
Latest News
|
25 February 2013
0 Likes
EU regulators have released for public consultation a guideline under development by the International Conference on Harmonisation (ICH) intended to establish the best practices for controlling
Read More...
Latest News
|
19 February 2013
1 Likes
What happens when your local regulatory agency isn't known as being reliable or capable at overseeing the safety and quality of products in your country? In at least one country, consumers could soon
Read More...
Latest News
|
11 February 2013
0 Likes
Canadian regulators have announced the suspension of all medical device licenses issued to or otherwise associated with one medical device manufacturer after being made aware of "concerns about the
Read More...
Latest News
|
7 February 2013
0 Likes
The International Conference on Harmonisation (ICH), the international pharmaceutical regulatory harmonization body, has released a draft guidance on the best practices for controlling carcinogenic
Read More...
Latest News
|
5 February 2013
0 Likes
Crises are rarely ones of regulators' own choosing. So in 2012 when pharmaceutical compounding became the topic de jure after a massive outbreak of fungal meningitis, state and federal regulators
Read More...